AfyaIndex
Kenyan Reference & Directory
Free lookups: 1/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
Drug categories Interaction checker
1 of 3 free lookups remaining Upgrade
New search Medicine profile Aspartame
Check interactions

Clinical medicine profile

Aspartame

Standardized Chemical Allergen [EPC], Copper-containing Intrauterine Device [EPC]

High alert POM
Evidence state Source-linked Review date not recorded
Route
SC / IV (soluble in critical care)
Schedule
POM
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

High-alert medicine — use an independent double-check during prescribing, preparation, and dispensing.

Contraindications

  • Hypoglycaemia.
  • Hypersensitivity to specific formulation.

Precautions

  • WARNINGS: If pregnant or breastfeeding, ask a health professional before use.
  • Keep out of reach of children.
  • In case of overdose, contact a physician or Poison Control Center right away.
  • Tamper Evident: Sealed for your protection.
  • Do not use if seal is broken or missing.
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Reduced insulin clearance — lower doses often needed in advanced CKD.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Impaired gluconeogenesis increases hypo risk.

03 Clinical use

Use, effects & interactions

Indications

  • USES: • For the temporary relief of symptoms including: • headache • liver support • muscle weakness • skin irritation • poor muscle coordination These statements are based upon homeopathic principles.
  • They have not been reviewed by the Food and Drug Administration.

Adverse effects

  • Hypoglycaemia, weight gain, injection-site reactions, lipodystrophy.
  • Rare: severe allergy, hypokalaemia (shift).

Drug interactions

Open multi-drug checker ↗
  • ISMP high-alert.
  • Write units in full.
  • Confirm concentration (U-100 vs U-200/U-300/U-500).
  • Sick-day rules and ketone advice for type 1.
  • Structured education improves outcomes.
04 Pharmacology

Mechanism & disposition

Insulin binds insulin receptors, promoting GLUT4-mediated glucose uptake in muscle/adipose tissue, stimulating glycogenesis, inhibiting glycogenolysis/gluconeogenesis and lipolysis — lowers blood glucose.

Insulin binds insulin receptors, promoting…
Read complete mechanism

Insulin binds insulin receptors, promoting GLUT4-mediated glucose uptake in muscle/adipose tissue, stimulating glycogenesis, inhibiting glycogenolysis/gluconeogenesis and lipolysis — lowers blood glucose.

Onset

Minutes–hours (formulation-dependent)

Duration

Hours–>40 h (basal analogues)

Route

SC / IV (soluble in critical care)

Absorption

varies by site, temperature, lipohypertrophy. Analogues engineered for prandial vs basal profiles. IV soluble insulin used in DKA/HHS protocols.

05 Special populations

Pregnancy, lactation & diet

Pregnancy

Insulin is preferred pharmacological therapy for diabetes in pregnancy when needed.

Lactation

Compatible; may need dose adjustment postpartum.

06 Kenya market

Brands & loaded prices

From—
Median—
Listings0
BrandManufacturerPackObserved price
No reviewed brand listings are linked yet.
07 Provenance

Sources & review state

Primary sourceFDA drug label via OpenFDA/DailyMed; Local active-ingredient clinical extract; Professional class pharmacology (Insulin (antidiabetic hormone))
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.